Osaka, Japan

Atsushi Takayanagi

This inventor holds 1 USPTO granted patent. Top assignees: A Biotech Co., Ltd., Gsp Enterprise, Inc., Tomoike Bio Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Takayanagi. Retrieved from https://idiyas.com/inventor/atsushi-takayanagi-ixq0yr9j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsushi Takayanagi: Innovator in Antibody Development

Introduction

Atsushi Takayanagi is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to advancements in medical research and therapeutic applications.

Latest Patents

Atsushi Takayanagi holds a patent for the "Anti-Human Cripto-1 Antibody." This invention represents a crucial step in understanding and potentially treating various diseases. The patent showcases his expertise and commitment to advancing medical science.

Career Highlights

Throughout his career, Takayanagi has worked with notable companies, including Tomoike Bio Ltd. and GSP Enterprise, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Sekyoung Lee and Masaharu Seno. Their collaborative efforts have further enhanced the impact of Takayanagi's work in the biotechnology sector.

Conclusion

Atsushi Takayanagi's contributions to antibody development highlight his role as an influential inventor in the field of biotechnology. His patent and collaborations reflect his dedication to advancing medical research and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…